Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Hematology Reports|August 7, 2003
Reduced-intensity allogeneic stem cell transplantationScott I Bearman
American Journal of Clinical Oncology|June 1, 2005
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapyYago Nieto, Elizabeth J Shpall, Scott I Bearman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapyYago Nieto, Samia Nawaz, Elizabeth J Shpall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancerYago Nieto, Samia Nawaz, Roy B Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 7, 2005
Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignanciesYago Nieto, Elizabeth J Shpall, Scott I Bearman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiationYago Nieto, Nigel Patton, Timothy Hawkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancerYago Nieto, James J Vredenburgh, Elizabeth J Shpall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)Douglas W Blayney, Michael L LeBlanc, Thomas Grogan, et al.
Kidney International|July 12, 2002
Renal dysfunction in allogeneic hematopoietic cell transplantationChirag R Parikh, Peter A McSweeney, Didem Korular, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplantYago Nieto, Elizabeth J Shpall, Ian K McNiece, et al.
Pageof 2